EVE Health GroupASX:EVE -5.56% PB Ratio is 1.31 as of Jul. 11, 2026, which is 10% below its 10-year median of 1.45. The stock has 6 warning signs investors should review. Among 1,894 Consumer Packaged Goods companies, EVE Health Group ranks worse than 51.21% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), EVE Health Group's share price is A$0.017. EVE Health Group's Book Value per Share for the quarter that ended in Dec. 2025 was A$0.01. Hence, EVE Health Group's PB Ratio of today is 1.31.
Warning Sign:
EVE Health Group Ltd stock PB Ratio (=1.46) is close to 1-year high of 1.46.
The historical rank and industry rank for EVE Health Group's PB Ratio or its related term are showing as below:
ASX:EVE'
s PB Ratio Range Over the Past 10 Years
Min: 0.38 Med: 1.45 Max: 4.44
Current: 1.31
During the past 13 years, EVE Health Group's highest PB Ratio was 4.44. The lowest was 0.38. And the median was 1.45.
ASX:EVE's PB Ratio is ranked worse than 51.21% of 1894
companies
in the Consumer Packaged Goods industry
Industry Median: 1.36
vs ASX:EVE: 1.31
During the past 12 months, EVE Health Group's average Book Value Per Share Growth Rate was 333.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -22.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -34.70% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -15.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of EVE Health Group was 128.80% per year. The lowest was -56.70% per year. And the median was -8.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
EVE Health Group PB Ratio Related Terms
EVE Health Group PB Ratio Historical Data
* Premium members only.
The historical data trend for EVE Health Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, EVE Health Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where EVE Health Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
EVE Health Group (ASX:EVE) has a PB Ratio of 1.31 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on EVE Health Group and its competitors. This is 10% below median its historical median of 1.45. Over the past decade, EVE Health Group's PB Ratio has ranged from 0.38 to 4.44. According to the industry distribution chart, EVE Health Group ranks #970 out of 1894 companies in the Consumer Packaged Goods industry, placing it in the top 51.2%.
Is EVE Health Group's PB Ratio too high?
EVE Health Group's current PB Ratio of 1.31 is 10% below median its 10-year median of 1.45. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 4.44. The Consumer Packaged Goods industry median PB Ratio is 1.36. EVE Health Group's value of 1.31 is 3.7% below this industry median. Based on the distribution chart, EVE Health Group ranks #970 out of 1894 companies in the Consumer Packaged Goods industry, which is below the industry midpoint.
How does EVE Health Group's PB Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #970 out of 1894 companies for PB Ratio. This places EVE Health Group in the lower half of its industry. The industry median PB Ratio is 1.36. EVE Health Group's value of 1.31 is 3.7% below this benchmark. Historically, EVE Health Group's own PB Ratio has ranged from 0.38 to 4.44 over the past decade. While the company's 10-year median is 1.45 vs. the industry median of 1.36, EVE Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.36, based on 1,894 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EVE Health Group's current PB Ratio of 1.31 is 3.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current PB Ratio is 1.31, which is 10% below median its own 10-year median of 1.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current PB Ratio is 1.31, which is 10% below median its 10-year median of 1.45 and 3.7% below the Consumer Packaged Goods industry median of 1.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current PB Ratio is 1.31 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 